Podcast9 – Podcasts App

Install

Squawk Pod

CNBC

Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.

Episodes

AstraZeneca in the Vaccine Race; Ballots in Georgia

Nov 23 2020 • 0 MIN

AstraZeneca’s Covid vaccine is the third one to prove highly effective in late-stage trials. AstraZeneca Executive Vice President Ruud Dobber explains differentiators of his company’s vaccine, and ...

Covid Milestones: Eli Lilly CEO on Antiviral Approval, Pfizer’s FDA Application, & Getting Back to the Movies

Nov 20 2020 • 0 MIN

Pfizer is submitting its application to the FDA for emergency use of its Covid-19 vaccine. If approved, administration of the vaccine could begin before the end of the year. The FDA has approved em...

SEC Chairman Exit Interview; Vaccine Supply & Distribution; David Boies & an Uncontestable Election

Nov 19 2020 • 0 MIN

David Boies, the lawyer who counseled former Vice President Al Gore in the 2000 election Florida recount, says President Trump will be unable to overturn the 2020 election results. Covid-19 cases a...

Boeing’s 737 Max Returns; Pfizer’s Covid Vaccine Proves 95% Effective

Nov 18 2020 • 0 MIN

As Covid cases rise and states impose new curfews to stem the spread, Pfizer & BioNtech have unveiled their coronavirus vaccine’s final data analysis. Their vaccine proved 95% effective in preventi...

Buffett’s Quarterly Bets; Tesla’s Index Inclusion; Amazon’s Drug Biz; Newsmax’s Editorial Appeal

Nov 17 2020 • 0 MIN

The S&P 500 will finally add Tesla to its index in mid-December. Elon Musk’s electric vehicle company now tops $400B in market cap. Warren Buffett’s Berkshire Hathaway made some changes to its equi...

The 94.5%: Moderna’s Covid Vaccine with CEO Stephane Bancel

Nov 16 2020 • 0 MIN

In Moderna’s ongoing clinical trial, the drugmaker’s Covid vaccine proved 94.5% effective in preventing the coronavirus. In an exclusive interview, CEO Stephane Bancel and CNBC’s Meg Tirrell discus...